The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition

Regulation of the Immune Response by the Aryl Hydrocarbon Receptor

(2018) Cristina Gutiérrez-Vázquez et al.   IMMUNITY

The Aryl Hydrocarbon Receptor and Tumor Immunity

(2018) Ping Xue et al.   Frontiers in Immunology

Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers

(2018) Jeffrey A. Knauf et al.   JOURNAL OF CLINICAL INVESTIGATION

TCDD promoted EMT of hFPECs via AhR, which involved the activation of EGFR/ERK signaling

(2016) Zhan Gao et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells

(2015) Jie Cheng et al.   Nature Communications

A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC

(2015) Gianluca Occhi et al.   Oncotarget

Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment

(2014) Sonia Moretti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

AHR Over-Expression in Papillary Thyroid Carcinoma: Clinical and Molecular Assessments in a Series of Italian Acromegalic Patients with a Long-Term Follow-Up

(2014) Caterina Mian et al.   PLoS One

Role of aryl hydrocarbon receptor in cancer

(2013) Shaolong Feng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells

(2013) Kai Wang et al.   CANCER LETTERS

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

(2011) Debyani Chakravarty et al.   JOURNAL OF CLINICAL INVESTIGATION

Global Analysis of BRAFV600E Target Genes in Human Melanocytes Identifies Matrix Metalloproteinase-1 as a Critical Mediator of Melanoma Growth

(2011) Byungwoo Ryu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

(2011) Christiane A. Opitz et al.   NATURE

Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice

(2011) A. T. Franco et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endometriosis-associated Skeletal Muscle Regeneration: A Hitherto Undescribed Entity and a Potential Diagnostic Pitfall

(2009) Renato Colella et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention

(2009) Vasilis P Androutsopoulos et al.   BMC CANCER

The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis

(2009) Y. Fan et al.   CANCER RESEARCH

Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation

(2009) Julie M. Hall et al.   MOLECULAR ENDOCRINOLOGY

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

(2008) Rebecca E. Schweppe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM